Steven Cohen Immatics N.V. Transaction History
Point72 Asset Management, L.P.
- $51 Billion
- Q3 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Immatics N.V. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 118,189 shares of IMTX stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
118,189Holding current value
$1.21 Million% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding IMTX
# of Institutions
67Shares Held
93MCall Options Held
53.8KPut Options Held
0-
T. Rowe Price Investment Management, Inc. Baltimore, MD19.4MShares$198 Million0.1% of portfolio
-
Baker Bros. Advisors LP New York, NY12.1MShares$123 Million0.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY12MShares$123 Million3.08% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$95.7 Million0.18% of portfolio
-
Rtw Investments, LP New York, NY8.82MShares$89.9 Million1.0% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $778M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...